BioCentury
ARTICLE | Clinical News

UC1010: Completed Phase I/II enrollment

January 6, 2014 8:00 AM UTC

On Dec. 16, 2013, Umecrine said its Umecrine Mood AB subsidiary completed enrollment of about 120 women in a double-blind, placebo-controlled, Swedish Phase I/II trial evaluating up to 40 mg/mL subcut...